| News Archive |
|
|
 |
| Announcement of Notifiable Interest of Shares |
|
|
|
 |
| Announcement of Notifiable Interest of Shares |
|
|
|
 |
| Trading Update, Interim results for the six months ended 31 August 2005 and Board Changes |
|
|
|
 |
| Completion of acquisition and allotment of shares |
|
|
|
 |
|
|
 |
| Completion of Disposal and Resignation of Directors |
|
|
|
 |
| Notifiable interest in shares |
|
|
|
 |
| Notifiable interest in shares |
|
|
|
 |
| Acquisition, fund raising, disposal and trading update |
|
|
|
 |
|
|
 |
|
|
 |
| Announcement of Notifiable Interest of Shares |
|
|
|
 |
|
|
 |
| First Aid UK Meets Second Performance Target |
|
|
|
 |
|
|
 |
|
|
 |
| Optiscope Technologies achieves milestone |
|
|
|
 |
|
|
 |
| Notice of AGM and Annual Report and Accounts 2005 |
|
|
|
 |
| Earn-out Issue of Shares - MDS Meets Performance Targets |
|
|
|
 |
| Healthcare Enterprise Group PLC acquires CICS (Holdings) Limited for up to £3 million |
|
|
|
 |
| HCEG acquires Fertiligent to extend its range of reproductive health products |
|
|
|
 |
| HCEG delivers on strategy with maiden profits |
|
|
|
 |
| HCEG signs first distribution agreement for Chinese market |
|
|
|
 |
| HCEG formalises commercial presence in Japan |
|
|
|
 |
| HCEG extends portfolio of branded medical products with MeDilator acquisition |
|
|
|
 |
| Unique new Ebiox product passes tests for $300m market |
|
|
|
 |
|
|
 |
| Announcement of Notifiable Interest of Shares |
|
|
|
 |
| Notification of Preliminary Results |
|
|
|
 |
| Announcement of Notifiable Interest of Shares |
|
|
|
 |
|
|
 |
| Announcement of notifiable interest of shares |
|
|
|
 |
|
|
 |
| Crest Meets First Performance Target |
|
|
|
 |
|
|
 |
|
|
 |
| Ebiox Surface Disinfectant, Test Results |
|
|
|
 |
| First Aid Meets First Performance Target |
|
|
|
 |
| Increased shareholding in Optiscope Technologies Ltd |
|
|
|
 |
| Directors interests in shares |
|
|
|
 |
| Ebiox Healthcare Decontamination Products: Asian Contract Win |
|
|
|
 |
| Contracts in US and Asia spur HCEG to acquire remaining 49% of Ebiox Limited |
|
|
|
 |
| Share capital consolidation, renewal of authority to allot ordinary shares and dis-application of statutory pre-emption rights |
|
|
|
 |
| Acquisition of minority interests and other transactions relating to SafaTec (UK) Limited Related Party Disclosure |
|
|
|
 |
| Extraordinary General Meeting Proposed Ordinary Share Capital Consolidation |
|
|
|
 |
| Appointment of Finance Director |
|
|
|
 |
| Ebiox Handrub - Health Protection Agency review confirms effectiveness against Hospital Acquired Infections |
|
|
|
 |
| Announcement of Notifiable Interest of Shares |
|
|
|
 |
| Completion of Acquisition |
|
|
|
 |
| Interim Results and the Acquisition of Crest Medical from Unichem Ltd |
|
|
|
 |
| Acquisition of Crest Medical from UniChem Ltd |
|
|
|
 |
| Appointment of Chief Executive Officer HCEG Europe Ltd |
|
|
|
 |
| Extraordinary General Meeting - Approval for acquisitions |
|
|
|
 |
| Optiscope time to market, accelerated through agreement with Wahl Optoparts |
|
|
|
 |
| $10 million dollar contract for the use of Ebiox in the USA |
|
|
|
 |
|
|
 |
| Results for the period ended 28th February 2003 |
|
|
|
 |
| Commitment received to subscribe for ordinary shares of 0.1p each ("Ordinary Shares") and proposed issue of Warrants to subscribe Ordinary Shares |
|
|
|
 |
|
|
 |
|
|
 |
| Ebiox surface cleaning product passes tests required for US Environment Protection Agency approval |
|
|
|
 |
| Increased shareholding in Ebiox Limited |
|
|
|
 |
| Ebiox urges Government to back new technology in fight against MRSA |
|
|
|
 |
| Ebiox Handrub successfully completes EU tests |
|
|
|
 |
| Acquisition of Optiscope Technologies Ltd. Proprietary technology for disposable endoscopes |
|
|
|
 |
| Notice of AGM and Annual Report and Accounts 2004 |
|
|
|
 |
| Completed acquisition of First Aid UK Limited |
|
|
|
 |
|
|
 |
| Appointment of Non-Executive Director |
|
|
|
 |
| German distribution agreement |
|
|
|
 |
| Proposed acquisition of First Aid UK Limited |
|
|
|
 |
| Preliminary results for the year ended 29 February 2004 |
|
|
|
 |
| Ebiox launch into the veterinary market |
|
|
|
 |
| Ebiox milestones achieved - deferred consideration for the purchase of SafaTec stake |
|
|
|
 |
| Ebiox Cleaning Wipes NHS Agreement |
|
|
|
 |
| Nigel Wray increases interest |
|
|
|
 |
| Transfers Of Shares Of Healthcare Enterprise Group PLC |
|
|
|
 |
| Environment Protection Agency approval of Ebiox products |
|
|
|
 |
|
|
 |
| Application for admission to trading of additional shares |
|
|
|
 |
|
|
 |
| Proposed Increase In Holding To 49% In Leading Developer Of Patented Decontamination And Disinfection Products |
|
|
|
 |
| Acquisition of US Healthcare Advisory Firm and Related Interest |
|
|
|
 |
| Strategic Disposals of Portfolio Holdings to US Asset Managers |
|
|
|
 |
| Appointment of Chief Executive Officer HCEG Europe Ltd |
|
|
|
 |
|
|
 |
| Investment by Prestbury Investment Holdings |
|
|
|